🇺🇸 FDA
Pipeline program

Advair Diskus100/50 µg

38-2013

Approved small_molecule completed

Quick answer

Advair Diskus100/50 µg for Asthma is a Approved program (small_molecule) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TEVA PHARMACEUTICAL INDUSTRIES LTD
Indication
Asthma
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials